- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Partnering opportunities
- A complete cure for HBV
- A stable efficacious Toxoplasma vaccine
- Activating SMCHD1 to treat FSHD
- Improving vision outcomes in retinal detachment
- Intercepting inflammation with RIPK2 inhibitors
- Novel inhibitors for the treatment of lupus
- Novel malaria vaccine
- Precision epigenetics silencing SMCHD1 to treat Prader Willi Syndrome
- Rethinking CD52 a therapy for autoimmune disease
- Targeting minor class splicing
- Royalties distribution
- Start-up companies
- Partnering opportunities
- Collaborators
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- People
- Anne-Laure Puaux
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Alyssa Barry
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Daniel Gray
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Emma Josefsson
- Associate Professor Ethan Goddard-Borger
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Murphy
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeanne Tie
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Leanne Robinson
- Associate Professor Marco Herold Marco Herold
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Matthew Ritchie
- Associate Professor Melissa Davis
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Peter Czabotar
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Sandra Nicholson
- Associate Professor Sant-Rayn Pasricha
- Associate Professor Seth Masters
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Wai-Hong Tham
- Associate Professor Wei Shi
- Catherine Parker
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gemma Kelly
- Dr Gwo Yaw Ho
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Joanna Groom
- Dr John Wentworth
- Dr Kelly Rogers
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Melissa Call
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Samir Taoudi
- Dr Shalin Naik
- Dr Sheau Wen Lok
- Dr Simon Chatfield
- Dr Tracy Putoczki
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Joel Chibert
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Lew
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Gabrielle Belz
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor Jane Visvader
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marc Pellegrini
- Professor Marnie Blewitt
- Professor Melanie Bahlo
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Burgess
- Professor Tony Papenfuss
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Undergraduate
- Student research projects
- A new regulator of stemness to create dendritic cell factories for immunotherapy
- Advanced methods for genomic rearrangement detection
- Control of cytokine signaling by SOCS1
- Defining the protein modifications associated with respiratory disease
- Delineating the pathways driving cancer development and therapy resistance
- Developing a new drug that targets plasmacytoid dendritic cells for the treatment of lupus
- Development and mechanism of action of novel antimalarials
- Development of a novel particle-based malaria vaccine
- Development of tau-specific therapeutic and diagnostic antibodies
- Discovering novel therapies for major human pathogens
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Epigenetic biomarkers of tuberculosis infection
- Essential role of glycobiology in malaria parasites
- Evolution of haematopoiesis in vertebrates
- Human lung protective immunity to tuberculosis
- Identifying novel treatment options for ovarian carcinosarcoma
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigating the role of mutant p53 in cancer
- Microbiome strain-level analysis using long read sequencing
- Minimising rheumatic adverse events of checkpoint inhibitor cancer therapy
- Modelling spatial and demographic heterogeneity of malaria transmission risk
- Naturally acquired immune response to malaria parasites
- Predicting the effect of non-coding structural variants in cancer
- Structural basis of catenin-independent Wnt signalling
- Structure and biology of proteins essential for Toxoplasma parasite invasion
- T lymphocytes: how memories are made
- TICKER: A cell history recorder for longitudinal patient monitoring
- Targeting host pathways to develop new broad-spectrum antiviral drugs
- Targeting post-translational modifications to disrupting the function of secreted proteins
- Targeting the epigenome to rewire pro-allergic T cells
- Targeting the immune microenvironment to treat KRAS-mutant adenocarcinoma
- The E3 ubiquitin ligase Parkin and mitophagy in Parkinson’s disease
- The molecular controls on dendritic cell development
- Understanding malaria infection dynamics
- Understanding the genetics of neutrophil maturation
- Understanding the neuroimmune regulation of innate immunity
- Understanding the proteins that regulate programmed cell death at the molecular level
- Using cutting-edge single cell tools to understand the origins of cancer
- When healthy cells turn bad: how immune responses can transition to lymphoma
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Lilly Backshell
- Megan Kent
- Naomi Jones
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Wayne Cawthorne
- Wil Lehmann
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- WEHI.TV
Structural biology leader appointed Companion of the Order of Australia
12 June 2017
Walter and Eliza Hall Institute scientist Professor Peter Colman has been appointed a Companion of the Order of Australia, Australia’s highest civilian honour, as part of the Queen’s Birthday Honours List for 2017.
Order of Australia, Australia’s highest civilian honour
The award recognises Professor Colman’s scientific achievements, particularly in the fields of structural biology and medicinal chemistry, his leadership in the commercial translation of scientific discoveries, and his service to the scientific community.
A physics graduate of the University of Adelaide, Professor Colman undertook postdoctoral training in the United States, Germany (where he was mentored by Nobel Laureate Professor Robert Huber) and in Sydney.
In 1978 he joined CSIRO where he established X-ray crystallography, a technique used to study the three-dimensional structure of proteins at the atomic level.
of the influenza protein neuraminidase
There he solved the 3-D structure of the protein neuraminidase, which is used by the influenza virus to spread within the respiratory tract. Professor Colman subsequently co-founded a biotechnology company Biota Holdings Ltd, and discovered the first ever ‘neuraminidase inhibitor’ drug zanamivir (marketed as Relenza™), used to treat influenza. Neuraminidase inhibitors are now stockpiled by governments around the world for use in an influenza pandemic.
Professor Colman was Chief of the CSIRO Division of Biomolecular Engineering from 1989 to 1997 and Director of the Biomolecular Research Institute from 1991 to 2000, during which periods he fostered the practice of biologists and medicinal chemists working harmoniously.
Since 2001, Professor Colman has led the Structural Biology division at the Walter and Eliza Hall Institute, where he has focused on understanding the structure of the proteins that control cell survival and cell death. This research underpinned the development of a new class of anti-cancer agents, called BH3-mimetics, which override the survival signals keeping cancer cells alive. One such agent, venetoclax, is now in clinical use for treating certain forms of leukaemia.
Professor Colman said he was honoured to receive the award. “Structural biology lets us see molecules, understand how they work, and do something about it when human health is compromised,” he said. “It has been my good fortune that twice my curiosity about how biology works has led me to useful findings.”
Nobel Laureate and former Walter and Eliza Hall Institute
director Sir Frank Macfarlane Burnet
“First, in the 1980s at CSIRO, whilst seeking to understand the year-to-year variation in influenza viruses, my colleagues and I discovered neuraminidase inhibitors. Then, here at the Institute, I was fascinated by the molecular interactions that control cell death, and which are dysfunctional in cancer. With a very large team of scientists here and together with commercial partners, we have been able to bring a new class of anti-cancer agents to patients,” Professor Colman said.
Walter and Eliza Hall Institute director Professor Doug Hilton AO said Professor Colman had made a profound impact on health through a program of research spanning from fundamental to translational science. “Peter’s research has contributed to drugs now in clinical use for treating influenza and leukaemia, which is testament to his commitment to research translation,” Professor Hilton said. “As well as collaborating with international pharmaceutical companies, he has founded two Australian biotech companies.
“Peter has long been recognised internationally as an eminent scientist in his field, but his impact on Australian medical research stretches far beyond this.
"He has been a wonderful mentor to many other scientists, and has been an advocate for fruitful multi-disciplinary collaborations. Peter’s service to the scientific community is also notable, through memberships of committees and boards, and other voluntary roles.”
Professor Colman’s scientific achievements have also been recognised by awards including:
- fellowship of the Australian Academy of Science (1989), the Australian Academy of Technological Sciences and Engineering (1997) and the Royal Society (2014)
- the Australian Academy of Science’s Macfarlane Burnet Medal (1995)
- the Australia Prize (1996, now called the Prime Minister’s Prize for Science)
- the Australian Institute of Policy & Science’s Florey Medal (2004)
- the Victoria Prize (2008)
In the Australian honours system, awards in the Order of Australia are the pre-eminent means of recognising outstanding achievement and contribution by Australian citizens.
Professor Colman is one of 15 Companions of the Order of Australia (AC) announced in the Queen's Birthday Honours List for 2017, together with Walter and Eliza Hall Institute alumnus Professor Peter Klinken.
For more information contact the Institute’s media team:
Ph: +61 475 751 811
Super Content:
Want to hear about our latest discoveries? Subscribe to our supporter newsletter, Illuminate.
Professor Andrew Roberts and collaborators have shown that patients with an advanced form of leukaemia can achieve complete remission with a novel tablet treatment.
The Colman Speed Honours Award is presented each year to our top Honours student.
The introduction of structural biology at the Institute gave our researchers a new way of looking at proteins
Dr Alfred Gottschalk discovered influenza neuraminidase in 1957, paving the way for the development of anti-flu drugs
Institute director Professor Doug Hilton was appointed an Officer of the Order of Australia in 2016